| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2018 | Antagonizing SET augments the effects of radiation therapy in hepatocellular carcinoma through reactivation of PP2A-Mediated akt downregulation | CHAO YUAN HUANG ; Hung M.-H.; Shih C.-T.; Hsieh F.-S.; Kuo C.-W.; Tsai M.-H.; Chang S.-S.; Hsiao Y.-J.; Chen L.-J.; Chao T.-I.; Chen K.-F. | Journal of Pharmacology and Experimental Therapeutics | 9 | 8 | |
| 2019 | Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced �]-catenin activation | Hung M.-H.; Chen Y.-L.; Chen L.-J.; Chu P.-Y.; Hsieh F.-S.; Tsai M.-H.; Shih C.-T.; Chao T.-I.; CHAO YUAN HUANG ; Chen K.-F. | Cell Death and Disease | 30 | 28 | |
| 2018 | Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia�Vmutated kinase�Vmediated DNA damage response | CHAO YUAN HUANG ; Hsieh F.-S.; Wang C.-Y.; Chen L.-J.; Chang S.-S.; Tsai M.-H.; Hung M.-H.; Kuo C.-W.; Shih C.-T.; Chao T.-I.; Chen K.-F. | European Journal of Cancer | 44 | 42 | |
| 2018 | Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma | Hu M.-H.; Huang T.-T.; Chao T.-I.; Chen L.-J.; Chen Y.-L.; Tsai M.-H.; Liu C.-Y.; JIA-HORNG KAO ; Chen K.-F. | Liver International | 5 | 5 | |
| 2017 | Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma | Hu M.-H.; Chen L.-J.; Chen Y.-L.; Tsai M.-S.; Shiau C.-W.; Chao T.-I.; Liu C.-Y.; JIA-HORNG KAO ; Chen K.-F. | Oncotarget | 16 | 12 | |
| 2021 | TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1 | Shih C.-T.; Shiau C.-W.; Chen Y.-L.; Chen L.-J.; Chao T.-I.; Wang C.-Y.; CHAO YUAN HUANG ; Hung M.-H.; Chen K.-F. | Cancer Letters | 8 | 8 |
